GeneDx Holding Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
1,000
- Stock Symbol
-
WGS
- Investments
-
1
- Share Price
-
$79.27
- (As of Friday Closing)
GeneDx Holding General Information
Description
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Contact Information
Website
www.genedx.comCorporate Office
- 333 Ludlow Street
- North Tower, 6th floor
- Stamford, CT 06902
- United States
Corporate Office
- 333 Ludlow Street
- North Tower, 6th floor
- Stamford, CT 06902
- United States
GeneDx Holding Timeline
GeneDx Holding Stock Performance
As of 24-Jan-2025, GeneDx Holding’s stock price is $79.27. Its current market cap is $2.18B with 27.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $79.27 | $77.66 | $2.98 - $98.87 | $2.18B | 27.5M | 715K | -$3.09 |
GeneDx Holding Financials Summary
As of 30-Sep-2024, GeneDx Holding has a trailing 12-month revenue of $267M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 1,153,260 | 30,701 | (11,340) | 625,750 |
| Revenue | 267,228 | 202,566 | 234,694 | 212,195 |
| EBITDA | (58,426) | (144,073) | (538,057) | (220,827) |
| Net Income | (83,497) | (175,767) | (548,980) | (245,390) |
| Total Assets | 408,840 | 418,756 | 490,942 | 554,093 |
| Total Debt | 116,101 | 119,770 | 77,134 | 11,000 |
GeneDx Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GeneDx Holding Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
GeneDx Holding Comparisons
Industry
Financing
Details
GeneDx Holding Competitors (19)
One of GeneDx Holding’s 19 competitors is Natera, a Formerly VC-backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Natera | Formerly VC-backed | Austin, TX | ||||
| Gene By Gene | Formerly VC-backed | Houston, TX | ||||
| Human Longevity | Venture Capital-Backed | San Diego, CA | ||||
| MedGenome | Venture Capital-Backed | Wilmington, DE | ||||
| Genoox | Private Equity-Backed | Palo Alto, CA |
GeneDx Holding Patents
GeneDx Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210110888-A1 | Method and system for assigning risk factors to individuals | Inactive | 11-Oct-2019 | ||
| US-20200388353-A1 | Automatic annotation of significant intervals of genome | Inactive | 06-Jun-2019 |
GeneDx Holding Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
GeneDx Holding Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
GeneDx Holding Acquisitions (1)
GeneDx Holding’s most recent deal was a Merger/Acquisition with CM Life Sciences. The deal was made on 22-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CM Life Sciences | 22-Jul-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
GeneDx Holding ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
GeneDx Holding FAQs
-
When was GeneDx Holding founded?
GeneDx Holding was founded in 2000.
-
Where is GeneDx Holding headquartered?
GeneDx Holding is headquartered in Stamford, CT.
-
What is the size of GeneDx Holding?
GeneDx Holding has 1,000 total employees.
-
What industry is GeneDx Holding in?
GeneDx Holding’s primary industry is Other Healthcare Technology Systems.
-
Is GeneDx Holding a private or public company?
GeneDx Holding is a Public company.
-
What is GeneDx Holding’s stock symbol?
The ticker symbol for GeneDx Holding is WGS.
-
What is the current stock price of GeneDx Holding?
As of 24-Jan-2025 the stock price of GeneDx Holding is $79.27.
-
What is the current market cap of GeneDx Holding?
The current market capitalization of GeneDx Holding is $2.18B.
-
What is GeneDx Holding’s current revenue?
The trailing twelve month revenue for GeneDx Holding is $267M.
-
Who are GeneDx Holding’s competitors?
Natera, Gene By Gene, Human Longevity, MedGenome, and Genoox are some of the 19 competitors of GeneDx Holding.
-
What is GeneDx Holding’s annual earnings per share (EPS)?
GeneDx Holding’s EPS for 12 months was -$3.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
